WHO Immunization Implementation Guide
0.2.0 - ci-build
WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions
| Draft as of 2025-09-17 |
<PlanDefinition xmlns="http://hl7.org/fhir">
<id value="IMMZD2DTDTPDelayed"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition"/>
<profile
value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<div>
<table class="grid dict">
<tr>
<th scope="row"><b>Id: </b></th>
<td style="padding-left: 4px;">IMMZD2DTDTPDelayed</td>
</tr>
<tr>
<th scope="row"><b>Url: </b></th>
<td style="padding-left: 4px;"><a href="PlanDefinition-IMMZD2DTDTPDelayed.html">IMMZ.D2.DT.DTP.Delayed or interrupted series</a></td>
</tr>
<tr>
<th scope="row"><b>Version: </b></th>
<td style="padding-left: 4px;">0.2.0</td>
</tr>
<tr>
<th scope="row"><b>Title: </b></th>
<td style="padding-left: 4px;">IMMZ.D2.DT.DTP.Delayed or interrupted series</td>
</tr>
<tr>
<th scope="row"><b>Status: </b></th>
<td style="padding-left: 4px;">draft</td>
</tr>
<tr>
<th scope="row"><b>Type: </b></th>
<td style="padding-left: 4px;">
<p style="margin-bottom: 5px;">
<b>system: </b> <span><a href="http://terminology.hl7.org/6.5.0/CodeSystem-plan-definition-type.html">http://terminology.hl7.org/CodeSystem/plan-definition-type</a></span>
</p>
<p style="margin-bottom: 5px;">
<b>code: </b> <span>eca-rule</span>
</p>
</td>
</tr>
<tr>
<th scope="row"><b>Date: </b></th>
<td style="padding-left: 4px;">2025-09-17 23:03:28+0000</td>
</tr>
<tr>
<th scope="row"><b>Publisher: </b></th>
<td style="padding-left: 4px;">WHO</td>
</tr>
<tr>
<th scope="row"><b>Description: </b></th>
<td style="padding-left: 4px;"><div><p>IMMZ.D2.DT.DTP.Delayed or interrupted series
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age</p>
</div></td>
</tr>
<tr>
<th scope="row"><b>Knowledge Capability: </b></th>
<td style="padding-left: 4px;">
computable
</td>
</tr>
<tr>
<th scope="row"><b>Related Artifacts: </b></th>
<td style="padding-left: 4px;">
<p><b>References</b></p>
<ul>
<li><div><p>WHO recommendations for routine immunization - summary tables (January 2025)</p>
</div><br/><a href="null"/></li>
</ul>
</td>
</tr>
<tr>
<th scope="row"><b>Libraries: </b></th>
<td style="padding-left: 4px;">
<table class="grid-dict">
<tr>
<td><a href="Library-IMMZD2DTDTPDelayedLogic.html">IMMZD2DTDTPDelayedLogic</a></td>
</tr>
</table>
</td>
</tr>
<tr>
<th scope="row"><b>Actions: </b></th>
<td style="padding-left: 4px;">
<table class="grid-dict">
<tr>
<td>
<b> Determine if the client is due for DTP.:</b> Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age
<br/>
<b>If:</b>
<i>Applicability:</i>
Client is due for DTP vaccination
<i>(Client is due for DTP vaccination)</i>
<br/>
<b>Then:</b> <i>Definition:</i> <a href="ActivityDefinition-IMMZD2DTDTPMR.html">IMMZ.D2.DT.DTP.MR</a><br/>
<i>Dynamic Values:</i><br/>
status: <i>('draft')</i>
<br/>
intent: <i>('proposal')</i>
<br/>
</td>
</tr>
<tr>
<td>
<b> Determine if the client is due for DTP.:</b> Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age
<br/>
<b>If:</b>
<i>Applicability:</i>
Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose
<i>(Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose)</i>
<br/>
<b>Then:</b> <i>Definition:</i> <a href="ActivityDefinition-IMMZD2DTDTPTdMR.html">IMMZ.D2.DT.DTP.Td.MR</a><br/>
<i>Dynamic Values:</i><br/>
status: <i>('draft')</i>
<br/>
intent: <i>('proposal')</i>
<br/>
</td>
</tr>
<tr>
<td>
<b> Determine if the client is due for DTP.:</b> Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age
<br/>
<b>If:</b>
<i>Applicability:</i>
Client is due for tetanus and diphtheria booster dose
<i>(Client is due for tetanus and diphtheria booster dose)</i>
<br/>
<b>Then:</b> <i>Definition:</i> <a href="ActivityDefinition-IMMZD2DTDTPTdMR.html">IMMZ.D2.DT.DTP.Td.MR</a><br/>
<i>Dynamic Values:</i><br/>
status: <i>('draft')</i>
<br/>
intent: <i>('proposal')</i>
<br/>
</td>
</tr>
<tr>
<td>
<b> Determine if the client is due for DTP.:</b> Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age
<br/>
<b>If:</b>
<i>Applicability:</i>
Primary DTP series is complete. Client is due for pertussis booster dose
<i>(Primary DTP series is complete. Client is due for pertussis booster dose)</i>
<br/>
<b>Then:</b> <i>Definition:</i> <a href="ActivityDefinition-IMMZD2DTDTPPMR.html">IMMZ.D2.DT.DTP.Pertussis.MR</a><br/>
<i>Dynamic Values:</i><br/>
status: <i>('draft')</i>
<br/>
intent: <i>('proposal')</i>
<br/>
</td>
</tr>
<tr>
<td>
<b> Check for Guidance for the patient regarding IMMZ.D2.DT.DTP.Delayed or interrupted series.:</b> Show Guidance for the patient regarding IMMZ.D2.DT.DTP.Delayed or interrupted series.
<br/>
<b>If:</b>
<i>Applicability:</i>
Has Guidance
<i>(Has Guidance)</i>
<br/>
<b>Then:</b> <i>Definition:</i> <a href="ActivityDefinition-IMMZD2DTCR.html">IMMZ.D2.DT.CR</a><br/>
<i>Dynamic Values:</i><br/>
status: <i>('active')</i>
<br/>
payload.contentString: <i>(Guidance)</i>
<br/>
category.coding: <i>(Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })</i>
<br/>
priority: <i>(Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })</i>
<br/>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
</div>
</text>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability">
<valueCode value="computable"/>
</extension>
<url
value="http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTDTPDelayed"/>
<version value="0.2.0"/>
<name value="IMMZD2DTDTPDelayed"/>
<title value="IMMZ.D2.DT.DTP.Delayed or interrupted series"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
<code value="eca-rule"/>
</coding>
</type>
<status value="draft"/>
<experimental value="false"/>
<date value="2025-09-17T23:03:28+00:00"/>
<publisher value="WHO"/>
<contact>
<name value="WHO"/>
<telecom>
<system value="url"/>
<value value="http://who.int"/>
</telecom>
</contact>
<description
value="IMMZ.D2.DT.DTP.Delayed or interrupted series
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age"/>
<relatedArtifact>
<type value="citation"/>
<citation
value="WHO recommendations for routine immunization - summary tables (January 2025)"/>
</relatedArtifact>
<library
value="http://smart.who.int/immunizations/Library/IMMZD2DTDTPDelayedLogic"/>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="Delayed or interrupted DTP-containing series: for children whose vaccination series has been interrupted,
the series should be resumed without repeating previous doses. Children aged between 1 year and 7 years who have not
previously been vaccinated should receive 3 doses of vaccine following a 0, 1, 6-month schedule. Two subsequent booster
doses using tetanus toxoid with reduced diphtheria toxoid (Td) or Td with acellular pertussis (TdaP) combination vaccines
are needed with an interval of at least 1 year between doses. For those starting a tetanus and diphtheria-containing
vaccination series in adolescence or adulthood: from 7 years of age only Td combinations should be used. Age-appropriate
combinations-containing pertussis vaccine with reduced diphtheria toxoid are also available. If tetanus vaccination is
started during adolescence or adulthood, a total of only 5 appropriately spaced doses are required to obtain lifelong
protection. Pregnant women and their newborn infants are protected from birth-associated tetanus if the mother received
either 6 tetanus-containing vaccine doses during childhood or 5 doses if first vaccinated during adolescence/adulthood
(documented by card, immunization registry and/or history) before the time of reproductive age. Vaccination history should
be verified in order to determine whether a dose of tetanus-containing vaccine is needed in the current pregnancy. In
countries where maternal and neonatal tetanus remains a public health problem, pregnant women for whom reliable information
on previous tetanus vaccinations is not available should receive at least 2 doses of tetanus-containing vaccines, preferably
Td, with an interval of at least 4 weeks between doses and the second dose at least 2 weeks before the birth. To ensure
protection for a minimum of 5 years, a third dose should be given at least 6 months later. A fourth and fifth dose should
be given at intervals of at least 1 year, or in subsequent pregnancies, in order to ensure lifelong protection. In
countries where maternal and neonatal tetanus is not a public health problem (low prevalence/high-income settings),
policy-makers may choose not to include tetanus vaccination among antenatal care interventions if effective tetanus
immunization programmes and good post-exposure prophylaxis exist outside of pregnancy. In countries where maternal
and neonatal tetanus is not a public health problem, the strategy may be to protect against tetanus via the infant
(3 DTP-containing vaccinations) and boosters programme. For more information, see the WHO guide Protecting all against
tetanus (5). For children aged under 7 years, diphtheria and tetanus toxoids and whole-cell pertussis (DTwP) or DTaP
combinations may be used. For children aged 4 years and older, Td-containing vaccine may be used and is preferred. For
children aged 7 years and older, only Td combinations should be used. Age-appropriate combinations-containing pertussis
vaccine with low-dose diphtheria antigen are also available. Only aP-containing vaccines should be used for vaccination
of persons aged 7 years and older."/>
</extension>
<title value="Determine if the client is due for DTP."/>
<description
value="Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age"/>
<condition>
<kind value="applicability"/>
<expression>
<description value="Client is due for DTP vaccination"/>
<language value="text/cql-identifier"/>
<expression value="Client is due for DTP vaccination"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTDTPMR"/>
<dynamicValue>
<path value="status"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'draft'"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="intent"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'proposal'"/>
</expression>
</dynamicValue>
</action>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="Delayed or interrupted DTP-containing series: for children whose vaccination series has been interrupted,
the series should be resumed without repeating previous doses. Children aged between 1 year and 7 years who have not
previously been vaccinated should receive 3 doses of vaccine following a 0, 1, 6-month schedule. Two subsequent booster
doses using tetanus toxoid with reduced diphtheria toxoid (Td) or Td with acellular pertussis (TdaP) combination vaccines
are needed with an interval of at least 1 year between doses. For those starting a tetanus and diphtheria-containing
vaccination series in adolescence or adulthood: from 7 years of age only Td combinations should be used. Age-appropriate
combinations-containing pertussis vaccine with reduced diphtheria toxoid are also available. If tetanus vaccination is
started during adolescence or adulthood, a total of only 5 appropriately spaced doses are required to obtain lifelong
protection. Pregnant women and their newborn infants are protected from birth-associated tetanus if the mother received
either 6 tetanus-containing vaccine doses during childhood or 5 doses if first vaccinated during adolescence/adulthood
(documented by card, immunization registry and/or history) before the time of reproductive age. Vaccination history should
be verified in order to determine whether a dose of tetanus-containing vaccine is needed in the current pregnancy. In
countries where maternal and neonatal tetanus remains a public health problem, pregnant women for whom reliable information
on previous tetanus vaccinations is not available should receive at least 2 doses of tetanus-containing vaccines, preferably
Td, with an interval of at least 4 weeks between doses and the second dose at least 2 weeks before the birth. To ensure
protection for a minimum of 5 years, a third dose should be given at least 6 months later. A fourth and fifth dose should
be given at intervals of at least 1 year, or in subsequent pregnancies, in order to ensure lifelong protection. In
countries where maternal and neonatal tetanus is not a public health problem (low prevalence/high-income settings),
policy-makers may choose not to include tetanus vaccination among antenatal care interventions if effective tetanus
immunization programmes and good post-exposure prophylaxis exist outside of pregnancy. In countries where maternal
and neonatal tetanus is not a public health problem, the strategy may be to protect against tetanus via the infant
(3 DTP-containing vaccinations) and boosters programme. For more information, see the WHO guide Protecting all against
tetanus (5). For children aged under 7 years, diphtheria and tetanus toxoids and whole-cell pertussis (DTwP) or DTaP
combinations may be used. For children aged 4 years and older, Td-containing vaccine may be used and is preferred. For
children aged 7 years and older, only Td combinations should be used. Age-appropriate combinations-containing pertussis
vaccine with low-dose diphtheria antigen are also available. Only aP-containing vaccines should be used for vaccination
of persons aged 7 years and older."/>
</extension>
<title value="Determine if the client is due for DTP."/>
<description
value="Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age"/>
<condition>
<kind value="applicability"/>
<expression>
<description
value="Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose"/>
<language value="text/cql-identifier"/>
<expression
value="Primary DTP series is complete. Client is due for tetanus and diphtheria booster dose"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTDTPTdMR"/>
<dynamicValue>
<path value="status"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'draft'"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="intent"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'proposal'"/>
</expression>
</dynamicValue>
</action>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="Delayed or interrupted DTP-containing series: for children whose vaccination series has been interrupted,
the series should be resumed without repeating previous doses. Children aged between 1 year and 7 years who have not
previously been vaccinated should receive 3 doses of vaccine following a 0, 1, 6-month schedule. Two subsequent booster
doses using tetanus toxoid with reduced diphtheria toxoid (Td) or Td with acellular pertussis (TdaP) combination vaccines
are needed with an interval of at least 1 year between doses. For those starting a tetanus and diphtheria-containing
vaccination series in adolescence or adulthood: from 7 years of age only Td combinations should be used. Age-appropriate
combinations-containing pertussis vaccine with reduced diphtheria toxoid are also available. If tetanus vaccination is
started during adolescence or adulthood, a total of only 5 appropriately spaced doses are required to obtain lifelong
protection. Pregnant women and their newborn infants are protected from birth-associated tetanus if the mother received
either 6 tetanus-containing vaccine doses during childhood or 5 doses if first vaccinated during adolescence/adulthood
(documented by card, immunization registry and/or history) before the time of reproductive age. Vaccination history should
be verified in order to determine whether a dose of tetanus-containing vaccine is needed in the current pregnancy. In
countries where maternal and neonatal tetanus remains a public health problem, pregnant women for whom reliable information
on previous tetanus vaccinations is not available should receive at least 2 doses of tetanus-containing vaccines, preferably
Td, with an interval of at least 4 weeks between doses and the second dose at least 2 weeks before the birth. To ensure
protection for a minimum of 5 years, a third dose should be given at least 6 months later. A fourth and fifth dose should
be given at intervals of at least 1 year, or in subsequent pregnancies, in order to ensure lifelong protection. In
countries where maternal and neonatal tetanus is not a public health problem (low prevalence/high-income settings),
policy-makers may choose not to include tetanus vaccination among antenatal care interventions if effective tetanus
immunization programmes and good post-exposure prophylaxis exist outside of pregnancy. In countries where maternal
and neonatal tetanus is not a public health problem, the strategy may be to protect against tetanus via the infant
(3 DTP-containing vaccinations) and boosters programme. For more information, see the WHO guide Protecting all against
tetanus (5). For children aged under 7 years, diphtheria and tetanus toxoids and whole-cell pertussis (DTwP) or DTaP
combinations may be used. For children aged 4 years and older, Td-containing vaccine may be used and is preferred. For
children aged 7 years and older, only Td combinations should be used. Age-appropriate combinations-containing pertussis
vaccine with low-dose diphtheria antigen are also available. Only aP-containing vaccines should be used for vaccination
of persons aged 7 years and older."/>
</extension>
<title value="Determine if the client is due for DTP."/>
<description
value="Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age"/>
<condition>
<kind value="applicability"/>
<expression>
<description
value="Client is due for tetanus and diphtheria booster dose"/>
<language value="text/cql-identifier"/>
<expression
value="Client is due for tetanus and diphtheria booster dose"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTDTPTdMR"/>
<dynamicValue>
<path value="status"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'draft'"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="intent"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'proposal'"/>
</expression>
</dynamicValue>
</action>
<action>
<extension
url="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale">
<valueMarkdown
value="The duration of protection following primary immunization varies considerably
depending upon factors such as local epidemiology, vaccination schedule and choice of vaccine. Therefore, a booster
dose is recommended for children aged 1–6 years, preferably during the second year of life (≥ 6 months after last
primary dose), unless otherwise indicated by local epidemiology; the contact could also be used to catch up on any
missed doses of other vaccines. This schedule should provide protection for at least 6 years for countries using
wP-containing vaccine. For countries using aP-containing vaccine, protection may decline appreciably before 6 years
of age. Only aP-containing vaccines should be used for vaccination of persons aged 7 years and older. Although a
booster dose in adolescence was shown to decrease disease in adolescents, this is not generally recommended as a
means of controlling pertussis in infants. A decision to introduce adolescent and/or adult boosters should only
be taken after careful assessment of local epidemiology, estimation of the contribution of adolescents as source
of infections of young infants, and selection of adolescents and/or adults as target groups for vaccination. Decisions
concerning such programmes should be based on the incidence and cost–effectiveness data. High coverage of routine
immunization in infants must be in place prior to the introduction of vaccination of adolescents and adults. "/>
</extension>
<title value="Determine if the client is due for DTP."/>
<description
value="Determine if the client is due for DTP vaccine according to the national immunization protocol.
DTP vaccination schedule for the following groups: children ≥ 1 year of age with no previous immunization, adolescents and adults with no previous immunization (including pregnant women) and supplementary immunization activities in high-risk areas, for women of reproductive age"/>
<condition>
<kind value="applicability"/>
<expression>
<description
value="Primary DTP series is complete. Client is due for pertussis booster dose"/>
<language value="text/cql-identifier"/>
<expression
value="Primary DTP series is complete. Client is due for pertussis booster dose"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTDTPPMR"/>
<dynamicValue>
<path value="status"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'draft'"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="intent"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'proposal'"/>
</expression>
</dynamicValue>
</action>
<action>
<title
value="Check for Guidance for the patient regarding IMMZ.D2.DT.DTP.Delayed or interrupted series."/>
<description
value="Show Guidance for the patient regarding IMMZ.D2.DT.DTP.Delayed or interrupted series."/>
<condition>
<kind value="applicability"/>
<expression>
<description value="Has Guidance"/>
<language value="text/cql-identifier"/>
<expression value="Has Guidance"/>
</expression>
</condition>
<definitionCanonical
value="http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTCR"/>
<dynamicValue>
<path value="status"/>
<expression>
<language value="text/cql-expression"/>
<expression value="'active'"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="payload.contentString"/>
<expression>
<language value="text/cql-identifier"/>
<expression value="Guidance"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="category.coding"/>
<expression>
<description value="Category of communication"/>
<language value="text/cql-expression"/>
<expression
value="Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' }"/>
</expression>
</dynamicValue>
<dynamicValue>
<path value="priority"/>
<expression>
<description value="Alert priority"/>
<language value="text/cql-expression"/>
<expression
value="Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' }"/>
</expression>
</dynamicValue>
</action>
</PlanDefinition>